Letrozole
Gestational Diabetes
Ain Shams UniversitySmall moleculePhase 4 / ApprovedDormant
BBB
76/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 64/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Gestational Diabetes cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metformin Ain Shams University | Phase 4 | A |
GLUCOSE, ANHYDROUS Siirt University | Phase 3 | B |
INSULIN SUSP ISOPHANE RECOMBINANT HUMAN University Hospital, Strasbourg, France | Phase 2 | CCC |
PANITUMUMAB University of North Carolina, Chapel Hill | N/A | D |
Folic Acid University of Messina | N/A | D |
Same molecule, other indications
Letrozole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →